Clinical Trial Update: Realizing Effectiveness Across Continents With Hydroxyurea (REACH) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers hydroxyurea in Phase 1/2 for sickle cell disease, with results posted on 2020-11-09.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2020-11-09